Nifty Pharma Prediction for Tomorrow, 17 July 2026: Index Nearly Flat at 26,008.05, Pausing After a Strong Two-Session Run
- July 16, 2026
- Posted by: Neeraj Pandey
- Category: News
Nifty Pharma prediction for tomorrow 17 July 2026: index at 26,008.05, up 0.02 percent on Thursday, pausing after two strong sessions. Support 25,935. Resistance 26,135 and 26,250.
Nifty pharma prediction for tomorrow: Nifty Pharma closed at 26,008.05 on Thursday, up just 4.45 points or 0.02 percent, essentially flat as the sector paused after two consecutive strong sessions that had lifted it 1.03 percent on Tuesday and a further 0.37 percent on Wednesday. This nifty pharma prediction for tomorrow is built on Friday, 10 July 2026’s closing data, the last completed session before markets reopen on Monday, 13 July 2026.
Ankit Jaiswal, Senior Research Analyst at Univest, notes that the Nifty Pharma prediction for tomorrow reflects a natural digestion phase, since the sector’s flat Thursday session, rather than an outright decline, suggests investors are holding onto recent gains rather than actively rotating out of pharma.
Click Here – Get Free Investment Predictions
Market Recap Behind the Nifty pharma prediction for tomorrow
The index opened at 26,060.90, touched a high of 26,135.75 and a low of 25,936.35 before closing at 26,008.05, essentially unchanged from Wednesday. Ankit Jaiswal notes that this pause came as market attention shifted to Nifty Chemicals and Nifty Consumer Durables, which led Thursday’s sectoral gains, a rotation that likely drew some flows away from pharma temporarily.
Nifty pharma prediction for tomorrow: Trend and Key Levels
Trend: Sideways Between 25,935 and 26,135
| Level Type | Value |
|---|---|
| Support 1 | 25,935 |
| Support 2 | 25,800 |
| Resistance 1 | 26,135 |
| Resistance 2 | 26,250 |
Ankit Jaiswal flags 25,935 as the key support, with 26,135 as the near-term resistance, matching Thursday’s high. A close above 26,250 would confirm the sector is resuming its earlier rally, while a break under 25,800 would suggest the two-session gains are beginning to unwind.
Global Cues for Nifty Pharma Tomorrow
Brent crude extended its climb for a fourth straight session after fresh US attacks on Iran overnight, yet domestic equity investors largely looked past the escalating Middle East tensions on Thursday, buoyed by a strong overnight Wall Street close and expectations of a robust Q1 FY27 earnings season. India VIX eased a further 2.94 percent to 12.88, its lowest level in over a week. Pharma remains largely insulated from these geopolitical and currency-driven cues, and Thursday’s pause looks more like a natural rotation shift than any change in the sector’s underlying defensive fundamentals.
Key Triggers in the Nifty pharma prediction for tomorrow
These triggers dominate the outlook heading into Monday, 13 July 2026:
- Rotation toward chemicals and consumer durables: These sectors led Thursday’s gains, potentially drawing flows away from pharma temporarily.
- US generic pricing developments: Any regulatory or pricing news from the US market remains an added sector-specific catalyst.
- HCL Technologies led Nifty gainers on Thursday, rising 1.66 percent to Rs 1,187.40, its second straight positive session and best single-day gain since Tuesday’s post-results crash.
Talk to a SEBI Registered Investment Advisor Before Your Next Trade
Stocks to Watch in the Pharma Sector
Key pharma constituents worth tracking alongside the broader sector outlook.
Sun Pharma: Sun Pharma is a sector bellwether worth tracking for stock-level signals within the pharma space.
Nifty Chemicals: Led Thursday’s sectoral gains, part of a broader rotation that may have temporarily drawn flows away from pharma.
Risks to the Nifty pharma prediction for tomorrow
These factors can invalidate this outlook:
- Extended pause turning into a reversal: If the sector fails to resume gains, it could suggest a more meaningful rotation away from defensives.
- US regulatory setback: Any adverse FDA decision would be a clear sector-specific negative.
- Continued flows into other sectors: Sustained strength in chemicals and consumer durables could keep pharma sidelined.
Download the Univest iOS App or Univest Android App to track live Nifty Pharma levels and get daily research from SEBI registered analysts.
Conclusion
The Nifty Pharma prediction for tomorrow, 17 July 2026, is sideways between 25,935 and 26,135, after the sector paused following two strong consecutive sessions. Ankit Jaiswal flags 25,935 as the key support in the Nifty Pharma prediction for tomorrow, treating Thursday’s flat session as healthy digestion rather than a reversal heading into Friday.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on the Nifty pharma prediction for tomorrow
What is the Nifty Pharma prediction for tomorrow, 17 July 2026?
Ans. The Nifty Pharma prediction for tomorrow, 17 July 2026, is sideways between 25,935 and 26,135. The index closed at 26,008.05 on Thursday, up just 0.02 percent, pausing after two strong consecutive sessions.
Which analyst gave the Nifty Pharma prediction for tomorrow?
Ans. Ankit Jaiswal, Senior Research Analyst at Univest, has shared the Nifty Pharma prediction for tomorrow, flagging 25,935 as the key support level.
Why did Nifty Pharma pause on Thursday?
Ans. Nifty Pharma paused on Thursday as market attention rotated toward Nifty Chemicals and Nifty Consumer Durables, which led the day’s sectoral gains, a shift the Nifty Pharma prediction for tomorrow reads as natural rotation rather than a reversal of the sector’s own defensive strength.
Is Nifty Pharma’s rally over after Thursday’s flat session?
Ans. The Nifty Pharma prediction for tomorrow treats Thursday’s pause as healthy digestion after gaining a combined 1.4 percent over Tuesday and Wednesday, not necessarily the end of the sector’s broader defensive rotation theme.